Promoting increased PrEP prescribing

Despite the efficacy of HIV preexposure prophylaxis (PrEP), utilization remains suboptimal with only about 25% to 30% of eligible individuals prescribed PrEP in 2021. Providers are pivotal in addressing multifaceted barriers to PrEP access. Financial barriers, HIV stigma, and limited knowledge hinder PrEP prescribing. Providers must understand PrEP guidelines, address stigma, and conduct structured sexual health screenings. Proactive measures including education initiatives and policy advocacy are vital. By fostering open communication and promoting inclusivity, providers can significantly enhance PrEP access, contributing to HIV prevention efforts and improved public health outcomes.